Apotheken
|
Doctor
|
Drugs
|
Hospital
|
Interactions
|
MiGeL
|
Registration owner
|
Services
Search result
- 53952
Price comparison
Price comparison and Component
Brand name
Component
Registration owner
Indication
Interaction
Unwanted Effect
Swissmedic-# (5-digit)
Pharmacode
Swissmedic Registration
53952
Date of registration
30.01.1997
Company name
Mundipharma Medical Company, Hamilton, Bermuda, Basel Branch
Revision date
31.01.2008
Valid until
Indication
Date of market entry
Index Therapeuticus (BSV)
01.01.30.
Revocation Date
Index Therapeuticus (Swissmedic)
01.01.30.
Information for professionals
IP
Seq.-No.
Product
Description
Galenic form
ATC-classification
01
Sevre-Long 30 mg
Kapseln retard
Delayed release capsules (Morphine Sulfate Pentahydrate 30 mg)
N02AA01
CI
02
Sevre-Long 60 mg
Kapseln retard
Delayed release capsules (Morphine Sulfate Pentahydrate 60 mg)
N02AA01
CI
04
Sevre-Long 120 mg
Kapseln retard
Delayed release capsules (Morphine Sulfate Pentahydrate 120 mg)
N02AA01
CI
06
Sevre-Long 200 mg
Kapseln retard
Delayed release capsules (Morphine Sulfate Pentahydrate 200 mg)
N02AA01
CI
ATC-Browser
|
Drugs A-Z
|
Recent Registrations
2024
©ywesee GmbH
Settings
|
Help
|
FAQ
|
Login
|
Contact
|
Home
